– Initial Phase 1 Data for CFT7455, a Novel IKZF1/3 Degrader, Expected in 1H 2022– – IND Clearance Achieved for CFT8634, a Degrader Targeting BRD9; On Track to Initiate Phase 1 Trial in Synovial ...
WATERTOWN, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science ...
Citroen is a brand in a state of flux as it, once again, finds itself fighting to find a distinct identity from its Peugeot sister brand under its new Stellantis parent company. It’s also had a ...
Citroen introduced the new C4 X and e-C4 X midsize fastback crossovers to slot between the regular C4 hatchback and the C5 X flagship. As described by Citroen CEO Vincent Cobée, the models are an ...
Citroen is a brand in a state of flux as it, once again, finds itself fighting to find a distinct identity from its Peugeot sister brand under its new Stellantis parent company. It’s also had a ...
Citroen’s new C4 small crossover has launched in one well-equipped Shine grade, ready for our family of testers. Our family of testers put the new Citroen C4 to the test. Iain: Your French heritage ...
Citroen has unveiled its new 2022 Citroen E-C4 and C4, the cars get a number of upgrades and improved range for the electric model. The new 2022 Citroen E-C4 will now come with a range of 217 miles ...
If you need a good, used seven-seat car but don’t want something that looks like a box with four wheels and some windows, what can you buy? Some would suggest the answer is the car you see here, the ...
WATERTOWN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results